TY - JOUR
T1 - Pediatric Living Donor Liver Transplantation for Congenital Absence of the Portal Vein With Pulmonary Hypertension
T2 - A Case Report
AU - Matsumoto, Naohisa
AU - Matsusaki, Takashi
AU - Hiroi, Kazumasa
AU - Kaku, Ryuji
AU - Yoshida, Ryuichi
AU - Umeda, Yuzo
AU - Yagi, Takahito
AU - Morimatsu, Hiroshi
N1 - Publisher Copyright:
© 2020 The Authors
PY - 2020/3
Y1 - 2020/3
N2 - Few reports of liver transplantation exist in patients with congenital absence of the portal vein and pulmonary hypertension. Living donor liver transplantation is usually performed before exacerbation of pulmonary hypertension. A 7-year-old girl (height: 131.5 cm; weight: 27.4 kg) with congenital absence of the portal vein was diagnosed with pulmonary hypertension (mean pulmonary artery pressure 35 mm Hg), and liver transplantation was planned before exacerbation of pulmonary hypertension. We successfully managed her hemodynamic parameters using low-dose dopamine and noradrenaline under monitoring of arterial blood pressure, central venous pressure, cardiac output, and stroke volume variation. Anesthesia was maintained using air-oxygen-sevoflurane and remifentanil 0.1 to 0.6 μg∙kg-1∙min-1. It is necessary to understand the potential perioperative complications in such cases and to adopt a multidisciplinary team approach in terms of the timing of transplantation and readiness to deal with exacerbation of pulmonary hypertension.
AB - Few reports of liver transplantation exist in patients with congenital absence of the portal vein and pulmonary hypertension. Living donor liver transplantation is usually performed before exacerbation of pulmonary hypertension. A 7-year-old girl (height: 131.5 cm; weight: 27.4 kg) with congenital absence of the portal vein was diagnosed with pulmonary hypertension (mean pulmonary artery pressure 35 mm Hg), and liver transplantation was planned before exacerbation of pulmonary hypertension. We successfully managed her hemodynamic parameters using low-dose dopamine and noradrenaline under monitoring of arterial blood pressure, central venous pressure, cardiac output, and stroke volume variation. Anesthesia was maintained using air-oxygen-sevoflurane and remifentanil 0.1 to 0.6 μg∙kg-1∙min-1. It is necessary to understand the potential perioperative complications in such cases and to adopt a multidisciplinary team approach in terms of the timing of transplantation and readiness to deal with exacerbation of pulmonary hypertension.
UR - http://www.scopus.com/inward/record.url?scp=85078804668&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078804668&partnerID=8YFLogxK
U2 - 10.1016/j.transproceed.2019.11.032
DO - 10.1016/j.transproceed.2019.11.032
M3 - Article
C2 - 32029317
AN - SCOPUS:85078804668
SN - 0041-1345
VL - 52
SP - 630
EP - 633
JO - Transplantation Proceedings
JF - Transplantation Proceedings
IS - 2
ER -